Identity
- Trade Name
- Identity™ FDA UDI
- Generic Name
- Shoulder reverse/standard adaptor prosthesis FDA UDI
- Model / Reference
- SAHAF135 FDA UDI
Identifiers
- Catalog Number
- SAHAF135 FDA UDI
- Primary DI / UDI-DI
- 00889024626492 FDA UDI
- 510(k) Number
- K213856 FDA UDI
- FDA Product Code
- MBF FDA UDIHSD FDA UDIKWS FDA UDIKWT FDA UDIPHX FDA UDI
- GMDN Term
- Shoulder reverse/standard adaptor prosthesis FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 888.3670 FDA UDI888.3690 FDA UDI888.3660 FDA UDI888.3650 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
Yes
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
MR Conditional FDA UDI
Category: Shoulder reverse/standard adaptor prosthesis
Identity™ by Zimmer, Inc. — Class II — MDR, FDA UDI — listed in FDA GUDID, EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Shoulder reverse/standard adaptor prosthesis.
- Arthrex® — Arthrex, Inc. · Class II
- Arthrex® — Arthrex, Inc. · Class II
- Identity™ — Zimmer, Inc. · Class II
Cleared under the same submission
K213856 also covers:
Authorization Coverage (2 countries)
Regulatory Authorizations
European Union Unknown
MDR
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | MDR | — | Class II | Unknown |
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Zimmer, Inc.
Sources (2)
- FDA UDI 3fd7ad61-361c-42c8-9f6a-b8d223857951 36 fields · synced Jun 18, 2026
- EUDAMED 1 fields · synced Jun 4, 2026